Skip to main content
Columvi 2.5 mg/2.5mL solution, concentrate by Genentech, Inc.
Columvi, 2.5 mg/2.5mL, solution, concentrate Drug class: Bispecific CD20-directed CD3 T Cell Engager. Available on prescription only. Listed by Genentech, Inc..
Prescription only

Columvi

Glofitamab

Listed by Genentech, Inc.

Strength
2.5 mg/2.5mL
Form
Solution, Concentrate
Route
Intravenous
Class
Bispecific CD20-directed CD3 T Cell Engager

What it contains

  • Glofitamab 2.5 mg/2.5mL

FDA record

Dosage form Solution, Concentrate
Route Intravenous
Drug class Bispecific CD20-directed CD3 T Cell Engager
Approval route BLA — biologic licence
NDC code 50242-125
FDA application BLA761309
RxNorm concept 2639786
Package sizes listed 1
Marketed since June 2023

Other products containing Glofitamab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Columvi

Glofitamab

Strength
10 mg/10mL
Form
Concentrate
Class
Bispecific CD20-directed CD3 T Cell Eng…
Rx only

Genentech, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.